A Pilot Study on the Effects of ILARIS on Patients With Proliferative Diabetic Retinopathy (PDRP)

Trial Profile

A Pilot Study on the Effects of ILARIS on Patients With Proliferative Diabetic Retinopathy (PDRP)

Discontinued
Phase of Trial: Phase I

Latest Information Update: 27 Nov 2015

At a glance

  • Drugs Canakinumab (Primary)
  • Indications Diabetic retinopathy
  • Focus Therapeutic Use
  • Most Recent Events

    • 23 Nov 2015 Status changed from recruiting to discontinued, as reported by ClinicalTrials.gov.
    • 14 Mar 2013 Additional lead trial centre identified as reported by ClinicalTrials.gov.
    • 08 May 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top